Back to top
more

Agilent Technologies (A)

(Delayed Data from NYSE)

$123.75 USD

123.75
1,475,965

+0.36 (0.29%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $123.78 +0.03 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (150 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Mark Vickery headshot

Dow and Small-Caps Close at New All-Time Highs

by Mark Vickery

The Dow closed at a fresh new high at 44,736, +440 points on the day, and the Russell 2000 notched its first all-time closing high since 2021.

Zacks Equity Research

Agilent Technologies (A) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 3.55% and 1.65%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Pre-Markets in the Green to Start Holiday-Shortened Week

by Zacks Equity Research

Pre-Markets in the Green to Start Holiday-Shortened Week

Mark Vickery headshot

Rally Continues to Start Thanksgiving Week

by Mark Vickery

Market participants look to be picking up where they left off last week.

Zacks Equity Research

Agilent to Report Q4 Earnings: What's in the Cards for the Stock?

by Zacks Equity Research

A's fourth-quarter performance is expected to have benefited from the growing ACG segment. However, falling end-market and regional sales raise concerns.

Zacks Equity Research

Stay Ahead of the Game With Agilent (A) Q4 Earnings: Wall Street's Insights on Key Metrics

by Zacks Equity Research

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.

Zacks Equity Research

Ametek (AME) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Ametek (AME) delivered earnings and revenue surprises of 2.47% and 0.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cognex Corporation (CGNX) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cognex (CGNX) delivered earnings and revenue surprises of 17.65% and 2.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent Expands LSAG Segment: How Should You Approach the Stock?

by Zacks Equity Research

A's expanding LSAG portfolio may bode well for the stock, despite macroeconomic risks and stretched valuation.

Zacks Equity Research

Danaher to Benefit From Business Strength Amid Headwinds

by Zacks Equity Research

DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.

Zacks Equity Research

Do Options Traders Know Something About Agilent Technologies (A) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Agilent Technologies (A) stock based on the movements in the options market lately.

Zacks Equity Research

Why Is Agilent (A) Up 1.2% Since Last Earnings Report?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Agilent (A) Reliance on International Sales: What Investors Need to Know

by Zacks Equity Research

Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks Equity Research

Agilent (A) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y

by Zacks Equity Research

Agilent's (A) fiscal third-quarter results reflect weakness across the Pharma, Food, Chemical and Advanced Materials, and Academic and Government markets.

Zacks Equity Research

Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 5.60% and 0.99%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns

by Zacks Equity Research

Agilent Technologies (A) launches J&W 5Q GC/MS Columns to address the growing demand for modern laboratories.

Zacks Equity Research

Agilent (A) Set to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Agilent's (A) fiscal third-quarter results are likely to reflect strength in the ACG and DGG segments despite the weak LSAG segment.

Zacks Equity Research

Wall Street's Insights Into Key Metrics Ahead of Agilent (A) Q3 Earnings

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2024.

Zacks Equity Research

Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Ametek (AME) Beats Q2 Earnings Estimates

by Zacks Equity Research

Ametek (AME) delivered earnings and revenue surprises of 1.22% and 2.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cognex Corporation (CGNX) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cognex (CGNX) delivered earnings and revenue surprises of 15% and 2.44%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System

by Zacks Equity Research

Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.

Zacks Equity Research

Why Is Agilent (A) Down 0.5% Since Last Earnings Report?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

New Strong Sell Stocks for June 7th

by Zacks Equity Research

A, CAR and BGS have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2024.